betterlife pharma.png
BetterLife Announces Closing of a Private Placement
July 02, 2024 18:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
June 26, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Announces Closing of a Private Placement
June 14, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
May 14, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Announces Intent to Complete Private Placement of Units
May 03, 2024 18:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Advances BETR-001 IND-enabling Studies
May 01, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm
April 12, 2024 15:06 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 12, 2024 (GLOBE NEWSWIRE) -- ​The Portnoy Law Firm advises Zoetis, Inc. (“Zoetis”)...
betterlife pharma.png
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 11, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
April 03, 2024 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
robbins-llp-logo-white-background1583450-1.png
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Fox Factory Holding Corp. (FOXF)
February 23, 2024 13:38 ET | Robbins LLP
Robbins LLP is Investigating the Allegations Against Fox Factory Holding Corp.